We’re excited to share that Evergen was recognized as the 2026 Best Overall Medtech Company in the 10th annual MedTech Breakthrough Awards program! The award recognizes Evergen’s agile, patient-first Contract Development and Manufacturing Organization (CDMO) partnership model and clinical expertise, which allows us to deliver the optimal biomaterial in the ideal form for each procedure. Evergen’s CEO, Olivier Visa said, “At our core, it is passion, agility, and an unwavering focus on improving patient outcomes that guide how we solve challenges for our partners and help them meet ambitious goals.” We are honored to be included among the outstanding organizations represented! Read more https://lnkd.in/en3-_wQR.